Narumi Y, Hricak H, Presti J C, Forstner R, Sica G T, Kuroda C, Sawai Y, Kotake T, Kinouchi T, Carroll P R
Department of Diagnostic Radiology, The Center for Adult Diseases, Osaka, Japan.
Abdom Imaging. 1997 Mar-Apr;22(2):216-25. doi: 10.1007/s002619900175.
This study examines the minimally required imaging protocol needed for detection and staging of renal cell carcinoma (RCC).
In 81 patients (21 women, 60 men; mean age = 62 years) with 85 RCCs, T1-weighted (T1WI), contrast-enhanced T1-weighted (Gd-T1WI), T2-weighted (T2WI), and gradient recalled echo-fast low flip angle shot (GRE/FLASH) images were evaluated alone and in combination. Surgical-pathological findings were available in all patients and were considered the standard of reference.
Tumor detection for lesions smaller than 3 cm was better on Gd-T1WI than on any other sequence, but only the comparison with noncontrast T1WI and GRE/FLASH was statistically significant (detection: T1WI = 33%, Gd-TIWI = 80%, T2WI = 60%, GRE = 47%). The respective accuracies of T1WI, Gd-T1WI, T2WI, and GRE/FLASH images were 81%, 78%, 71%, and 62% for evaluating local tumor extension; 90%, 88%, 89%, and 85% for lymphadenopathy; and 89%, 81%, 91%, and 95% for renal vein thrombus. The combination of T1WI and GRE sequences rendered the highest overall staging accuracy.
For tumor detection, contrast-enhanced T1WI is necessary for lesions smaller than 3 cm. For tumor staging, although the addition of GRE results in significant improvement in the evaluation of venous thrombus, any combination of two sequences will result in similar accuracy, and the use of multiple sequences is not necessary.
本研究探讨了肾细胞癌(RCC)检测与分期所需的最低成像方案。
对81例患者(21例女性,60例男性;平均年龄62岁)的85个肾细胞癌进行研究,单独及联合评估T1加权(T1WI)、对比增强T1加权(Gd-T1WI)、T2加权(T2WI)和梯度回波快速低翻转角成像(GRE/FLASH)图像。所有患者均有手术病理结果,将其视为参考标准。
对于小于3 cm的病变,Gd-T1WI的肿瘤检测效果优于其他任何序列,但仅与非增强T1WI和GRE/FLASH的比较具有统计学意义(检测率:T1WI = 33%,Gd-TIWI = 80%,T2WI = 60%,GRE = 47%)。T1WI、Gd-T1WI、T2WI和GRE/FLASH图像在评估局部肿瘤扩展方面的准确率分别为81%、78%、71%和62%;在评估淋巴结病变方面分别为90%、88%、89%和85%;在评估肾静脉血栓方面分别为89%、81%、91%和95%。T1WI和GRE序列联合使用时总体分期准确率最高。
对于肿瘤检测,小于3 cm的病变需要使用对比增强T1WI。对于肿瘤分期,虽然增加GRE序列可显著提高静脉血栓评估的准确性,但任意两个序列联合使用的准确率相似,无需使用多个序列。